Discovery Group results for 2026 show profit up 17% to R17.75bn, driven by Discovery Health, the Bank's turnaround and global Vitality growth.
You must be a subscriber to access all of this content.
Mandatory medical scheme membership for taxpayers could cut cover costs by up to 30%, HFA research finds, alongside a risk equalisation fund.
You must be a subscriber to access all of this content.
The 2025 Mediscor Medicines Review shows medicine spend up 4.7%, with generics, chronic care and speciality drugs shaping affordability.
You must be a subscriber to access all of this content.
Aspen Pharmacare earnings rose 22% as demand for Eli Lilly's weight-loss drug Mounjaro surged, with the group also eyeing generic semaglutide.
You must be a subscriber to access all of this content.
The government will bring traditional health practitioners into the NHI as regulation and benefit-sharing take shape.
You must be a subscriber to access all of this content.
Lenacapavir HIV prevention could accelerate South Africa’s epidemic control, but severe supply constraints are limiting the rollout.
You must be a subscriber to access all of this content.